Literature DB >> 10407139

New insights into an old protein: the functional diversity of mammalian glyceraldehyde-3-phosphate dehydrogenase.

M A Sirover1.   

Abstract

Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was considered a classical glycolytic protein examined for its pivotal role in energy production. It was also used as a model protein for analysis of protein structure and enzyme mechanisms. The GAPDH gene was utilized as a prototype for studies of genetic organization, expression and regulation. However, recent evidence demonstrates that mammalian GAPDH displays a number of diverse activities unrelated to its glycolytic function. These include its role in membrane fusion, microtubule bundling, phosphotransferase activity, nuclear RNA export, DNA replication and DNA repair. These new activities may be related to the subcellular localization and oligomeric structure of GAPDH in vivo. Furthermore, other investigations suggest that GAPDH is involved in apoptosis, age-related neurodegenerative disease, prostate cancer and viral pathogenesis. Intriguingly, GAPDH is also a unique target of nitric oxide. This review discusses the functional diversity of GAPDH in relation to its protein structure. The mechanisms through which mammalian cells may utilize GAPDH amino acid sequences to provide these new functions and to determine its intracellular localization are considered. The interrelationship between new GAPDH activities and its role in cell pathologies is addressed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10407139     DOI: 10.1016/s0167-4838(99)00119-3

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  216 in total

1.  Autophagosome-associated variant isoforms of cytosolic enzymes.

Authors:  M Fengsrud; C Raiborg; T O Berg; P E Strømhaug; T Ueno; E S Erichsen; P O Seglen
Journal:  Biochem J       Date:  2000-12-15       Impact factor: 3.857

2.  Sequence conserved for subcellular localization.

Authors:  Rajesh Nair; Burkhard Rost
Journal:  Protein Sci       Date:  2002-12       Impact factor: 6.725

Review 3.  Metabolic enzymes as targets for 14-3-3 proteins.

Authors:  Steven C Huber; Carol MacKintosh; Werner M Kaiser
Journal:  Plant Mol Biol       Date:  2002-12       Impact factor: 4.076

4.  Structural characterization of transglutaminase-catalyzed cross-linking between glyceraldehyde 3-phosphate dehydrogenase and polyglutamine repeats.

Authors:  Margherita Ruoppolo; Stefania Orrù; Simona Francese; Ivana Caputo; Carla Esposito
Journal:  Protein Sci       Date:  2003-01       Impact factor: 6.725

5.  Peptide-linked molecular beacons for efficient delivery and rapid mRNA detection in living cells.

Authors:  Nitin Nitin; Philip J Santangelo; Gloria Kim; Shuming Nie; Gang Bao
Journal:  Nucleic Acids Res       Date:  2004-04-14       Impact factor: 16.971

6.  The role of the Src family kinase Lyn in the immunomodulatory activities of cathelicidin peptide LL-37 on monocytic cells.

Authors:  Anastasia Nijnik; Jelena Pistolic; Patricia Cho; Niall C J Filewod; Reza Falsafi; Alexander Ramin; Kenneth W Harder; Robert E W Hancock
Journal:  J Leukoc Biol       Date:  2012-01-13       Impact factor: 4.962

Review 7.  Calcineurin homologous protein: a multifunctional Ca2+-binding protein family.

Authors:  Francesca Di Sole; Komal Vadnagara; Orson W Moe; Victor Babich
Journal:  Am J Physiol Renal Physiol       Date:  2011-12-21

8.  Novel protein haponin regulates cellular response to oxidative stress.

Authors:  E V Smirnova; T V Rakitina; O V Bogatova; D L Ivanova; E E Vorobyeva; A V Lipkin; I A Kostanyan; V M Lipkin
Journal:  Dokl Biochem Biophys       Date:  2011-11-19       Impact factor: 0.788

9.  Proteomic profiling of human bone marrow mesenchymal stem cells under shear stress.

Authors:  Wei Yi; Yang Sun; Xufeng Wei; Chunhu Gu; Xiaochao Dong; Xiaojun Kang; Shuzhong Guo; Kefeng Dou
Journal:  Mol Cell Biochem       Date:  2010-04-21       Impact factor: 3.396

Review 10.  Glyceraldehyde-3-phosphate dehydrogenase as a target for small-molecule disease-modifying therapies in human neurodegenerative disorders.

Authors:  Mark D Berry
Journal:  J Psychiatry Neurosci       Date:  2004-09       Impact factor: 6.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.